| Neurology Clinical Programs |
|
|
Help us fund research
that is changing lives 
Let us know about a "star" employee:  |
In the News Recent Interviews and ArticlesHow to Choose the Right Assistive Walking Device When You Have MS Dr. Riley Bove, alongside doctors from other institutions, offer their insight on the changing landscape of MS disability progression, and discuss appropriate ways to navigate and consider the various assistive devise options. By Heidi Godman for US News & World Report on May 19, 2017 After 40-year odyssey, first drug for aggressive MS wins FDA approval Following the highly anticipated FDA approval of the MS drug Ocrelizumab (Ocrevus), explore the enduring, and at times uncertain path leading to it's creation. By Ron Winslow for STAT News on March 28, 2017 Facebook Live Q&A with Neurologist & MS Expert, Dr. Sherman Jia Join us on Thursday, March 30th from 5-6PM (PDT) to watch Dr. Sherman Jia, one of our promising Fellows, field questions live on Healthline! Positive Multiple Sclerosis Clinical Trial Results Support New Treatment Approach Dr. Stephen L. Hauser, alongside the highly anticipated publication of Phase III trial results, explains the ‘unprecedented’ effects of Ocrevus on the relapsing form of MS. By Pete Farley on December 21, 2016 Think Like a Doctor: The Painter’s Headaches Follow along with neuroimmunology expert Dr. Jeffrey Gelfand as he works to solve this case. By Lisa Sanders, MD on November 3, 2016 California-wide initiative to bring precision medicine to patients Dr. Riley Bove and the MS BioScreen: “Making it work”, in partnership with Sutter Healthcare and the National MS Society. California Initiative to Advance Precision Medicine, 2016 Promoting remyelination in MS treatment Our Medical Director Dr. Ari Green, focuses on the visual system. Multiple Sclerosis Resource Centre, 2016 The new Weill Institute for Neurosciences: Building the Brain Clinics of the Future Dr. Riley Bove teams up with Doctors from other Neurology and Psychiatry groups across the new UCSF Weill Institute for Neurosciences to reimagine clinical care. UCSF Weill Institute for Neurosciences on October 27, 2016 In children with MS, a “vitamin D genetic risk score” may predict relapses Pediatric MS Drs. Graves and Waubant present data from the International Pediatric MS Network. By Brian Hoyle on October 18, 2016 How does MS change as women move towards menopause and beyond? Dr. Riley Bove’s research to date has focused on shedding light on the menopausal transition in women with MS. She is currently leading a hormone trial. How Does Menopause Affect Women With MS? By Alisa Woods, PhD on June 16, 2016 The Latest News On MS And Hormones – MCP’s Empowered By Dr. Riley Bove By Kate Milliken on July 26, 2016 The bacteria that live in our guts may shape our risk of developing immune disease UCSF researcher Dr. Sergio Baranzini is leading an international study to find the culprits. Baranzini Lab, UCSF on April 22, 2016 Aging Ovaries May Signal Imminent Progression of MS Drs. Graves and Oksenberg report that declines in levels of anti-mullerian hormone (AMH), a measure of ovarian reserve, may predict brain volume loss. By Caroline Helwick on February 22, 2016 2015 Society Leadership Conference Research Panel Dr. Ari Green and other leading MS researchers discuss recent topics at the 2015 Society Leadership Conference in Fort Worth, TX. NMSS on Nov 17, 2015 An exciting update to the B cell story Dr. Stephen Hauser discusses the promising future for B cell therapies. By Erin Biba on Oct 8, 2015 Next-Gen Genomic Tests Identify Brain-Eating Amoeba New UCSF Center Aims to Make Tests More Affordable and Accessible to Doctors. By Nicholas Weiler on September 8, 2015 New Center Will Advance Life-Saving Genome-Based Diagnostic Tools UCSF-Designed Tests Pinpoint Rare Infectious Agents Far More Rapidly Than Conventional Methods By Pete Farley on August 20, 2015 Learning About Neuroprotection for Multiple Sclerosis Treatment Q&A With Dr. Emmanuelle Waubant MD Magazine on Apr 29, 2015 Potential new therapeutics and the influence of diet Interview with Dr. Emmanuelle Waubant on potential new therapeutics and the influence of diet. Multiple Sclerosis Resource Centre, 2015 News ArchivesStriking a Nerve: Allergy Drug Tested for MS Ari Green, MD and Jonah Chan, PhD launch a clinical trial to evaluate the active ingredient in Tavist as a possible remyelinating agent for patients with multiple sclerosis. John Gever for MedPage Today February 06, 2014 What to know about clinical trials and MS Q & A with Dr. Emmanuelle Waubant JHo Editor February 04, 2014 Barancik Prize winner aims for myelin repair Jonah Chan, PhD, focuses on the potential of existing drugs to repair myelin. Vicky Uhland for NMSS Momentum Magazine, 2014 Multiple Sclerosis: Five sources to seek after diagnosis Dr. Elizabeth Crabtree and the UCSF MS Center support group were recognized as a top resource in the Bay Area by the San Jose Mercury News after a diagnosis of MS. By Jessica Yadegaran on 05/13/2013 Nutrition and MS Dr. Elizabeth Crabtree discusses nutrition and its impact on MS. Sorop Sounding Board on Apr 17, 2013 UCSF Neurologist Wins Top International Prize for Multiple Sclerosis Research Stephen Hauser Receives Lifetime Achievement Award April 05, 2013 Scientists Identify Key Biological Mechanism in Multiple Sclerosis Imaging Study Finds Potential New Target to Combat Disease By Anne Holden on November 30, 2012 Pictures from Pediatric MS Family Day Center Without Walls Research Project - Emmanuelle Waubant, MD, PhD - UCSF Meet Dr. Emmanuelle Waubant, Associate Professor of Neurology, Director Regional Pediatric MS Center at UCSF, and Director of the Nancy Davis Center Without Walls program. Here is an overview of her latest research - Pediatric MS. UC San Francisco tests new class of MS drugs Advances in MRI technology and cellular engineering are giving new hope to people fighting Multiple sclerosis. SmartPlanet visits the University of California at San Francisco and talks to Dr. Emannuelle Waubant about new drug therapy that is reducing brain lesions and cutting down on relapse for patients. Charlie Rose Brain Series 2, Episode 9: Multiple Sclerosis Dr. Stephen Hauser and colleagues talk about the current state of MS research and treatment interventions.  Vitamin D Dr. Stephen Hauser talks about Vitamin D with regard to multiple sclerosis. A GWAS Gets Into Shape Researchers connect gene variants to structure of brain lesions By Mitch Leslie on 14 Feb 2013 |